DOCSLIB.ORG

Syllabus of M. Pharm Session: 2013-2014 Examination: 2014

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Syllabus of M. Pharm Session: 2013-2014 Examination: 2014 1 Syllabus of M. Pharm Session: 2013-2014 Examination: 2014 Department of Pharmacy Faculty of Science University of Rajshahi 2 Ordinance of Master of Pharmacy. (1 year course) Duration of the Course: The M.Pharm course consisting of General and Thesis Groups shall extend over a period of one academic year. The degree has to be completed within a minimum of one academic year and in not more than three academic years from the date of first admission. Admission Requirements: For admission to the M.Pharm course in any subject of the faculty a student must have the following qualifications: B.Pharm Honours degree of four years duration of this University or of a recognized University in the subject or similar subject to be decided by the relevant department. A maximum of two years break of study after passing B.Pharm Honours examination shall be allowed. Candidates appearing at the Bachelor of Pharmacy Honours final examination from this University may be admitted provisionally to the Master of Pharmacy (M.Pharm) classes pending publication of their examination results: the confirmation of their admission being subject to their passing the examination as and when the results of examination are published. Course and Distribution of Marks: The total marks of Master Pharmacy examination (General and Thesis Group) shall be 1000 (10 course units, 40 credits) for all the subjects. The marks shall be distributed among the Theory Courses, Class assessment /Tutorial /Terminal /Home assignments, Viva Voce, Practical/Dissertation, Projects, Field Works, In-plant Training etc as follows: Courses Marks Units Credits a. Theory* 600 6 24 Class assessment /Tutorial/Terminal/Home assignment** 100 1 4 Viva Voce 100 1 4 b. Practical/Practical and In-plant Training/Field Work Project etc. 200 2 8 (30% marks to be allotted for continuous Lab assessment)* OR c. Thesis/Dissertation including Viva-Voce 200 2 8 (and/or Seminar)/In-plant training etc. 1000 10 40 * The Departments of (i) Mathematics and (ii) Applied Mathematics shall offer two additional Theory courses (2 units) instead of Practical courses as mentioned in (b). ** 20% of the assessment marks shall be awarded for attendance in the class on the basis of the following table: Attendance Marks Attendance Marks Attendance Marks 95-100% 20% 90-<95% 18% 85-<90% 16% 80-<85% 14% 75-<80% 12% 70-<75% 10% 65-<70% 8% 60-<65% 6% <60% 00% There shall be a minimum of 3 lecture periods per week totaling 60 lectures in an academic year for each theory course of 1.0 unit. There shall be 15-18 Laboratory hours per week totaling 300- 360 Lab-periods in an academic year for each Practical course of 2 units. Class assessment/Tutorial/Terminal/Home assignment examination on the Theory courses (at least 3 for 1 unit course) shall be taken by the course teacher(s) as internal evaluation during the progress of the course. The duration of examination of Theory course shall be 4 hours for 1 unit course. The total duration of Practical examination shall be 24-48 hours for 2 units (4-6 hours per day). Class assessment/Tutorial/Terminal/Home assignment and Lab-assessment marks (average) are to be submitted by the teachers concerned to the Chairman of the relevant examination Committee before the commencement of the final examination. Consolidated average marks of Class assessment /Tutorial /Terminal /Home assignment, Viva Voce, Lab-assessment and Practical courses are to be submitted to the Controller of examination by the Chairman of the relevant examination Committee before finalizing the result. Eligibility for Master of Pharmacy Examination: In order to be eligible for taking up the M.Pharm examination, a candidate must have pursued a regular course of study by attending not less than 75% of the total number of classes held (Theoretical, Practical, Class assessment /Tutorial /Terminal /Home assignment) provided that 3 the Academic Committee of the Department on special grounds and on such documentary evidence as may be necessary, may condone the cases of shortage of attendance ordinarily not below 60%. A candidate appearing at the examination under the benefit of this provision shall have to pay in addition to the examination fees, the requisite fee prescribed by the Syndicate for the purpose. A candidate, who failed to appear at the examination or fails to pass the examination, may on the approval of the relevant Department be readmitted to the following session. Admission to Master of Pharmacy Examination: Every candidate for admission to M.Pharm examination shall submit his/her application in the prescribed form together with certificates of attendance and fulfill all other conditions prescribed by the University. The application shall be submitted through the Chairman of the Department and Provost of the Hall concerned so as to reach the Controller of examinations at least six weeks before the date fixed for the commencement of the examination. Medium of Questions and Answers: Questions shall be made in English. The medium of answer in the examination of all courses shall be in English. Thesis/Dissertation: At least three copies of Thesis/Dissertation (typed, printed and hard-bound) shall have to be submitted to the Chairman of the relevant Examination Committee within the scheduled date (ordinarily three months after the completion of the written examination) of submission. One copy approved for M.Pharm degree shall be sent by the Chairman of the respective Examination Committee to the Departmental Seminar/University Library for future reference. Course Completion, Holding of Examination and Publication of Results: Courses should be conducted according to the Academic calendar circulated by the Department concerned and be completed within eight months from the commencement of the courses. The Practical examinations may be conducted immediately after the completion of written theory examination. The time-limit for the publication of the results of the M.Pharm examination shall ordinarily be six weeks (for General Group) from the date of completion of the written/practical/viva voce (whichever is the last) examination. The Grading Systems: Credit Point (CP): The credit points achieved by an examinee for 1 (one) unit course shall be 4 (four). Letter Grade (LG) and Grade Point (GP): Letter Grades, corresponding Grade Points and Credit Points shall be awarded in accordance with provisions shown below: Table of LG, GP and CP for credit courses Numerical grade LG GP/unit CP/unit 80% or its above A+ (A plus) 4.00 4 75% to less than 80% A (A regular) 3.75 4 70% to less than 75% A-(A minus) 3.50 4 65% to less than 70% B+ (B plus) 3.25 4 60% to less than 65% B (B regular) 3.00 4 55% to less than 60% B- (B minus) 2.75 4 50% to less than 55% C+ (C plus) 2.50 4 45% to less than 50% C (C regular) 2.25 4 40% to less than 45% D 2.00 4 Less than 40% F 0.00 0 Incomplete I -- 0 Absence from the final examination shall be considered incomplete with the letter grade “I”. Grade Point Average (GPA) and Total Credit Point (TCP): The weighted average of the grade points obtained in all the courses by a student and Total Credit Point shall be calculated from the following equations: GPA = Sum of [(CP)i x (GP)i] / sum of (CP)i and TCP = Sum of (CP)i Where (GP)i = grade point obtained in individual course, (CP)i = credit point for respective course, GPA = grade point average obtained, and TCP = total credit point obtained. GPA shall be rounded off up to 2 (two) places after decimal to the advantage of the examinee. For instance, GPA=2.112 4 shall be rounded off as GPA=2.12. An illustration of calculating GPA and CGPA: Suppose a student has completed six courses in M.Pharm examination and obtained the following grades: M.Pharm course Credits (CP) Grade (LG) GP 501 4 A 3.75 502 4 A+ 4.00 503 4 B+ 3.25 504 4 B- 2.75 505 4 C 2.25 506 4 F 0.00 ( ) ( ) ( ) ( ) ( ) +++++ 000425247524253400447534 .).(..... 0064 GPA = == .66672 +++++ 444444 24 His/her GPA is: 2.67 LG corresponding to GPA = 2.67 is “B-”. Award of Degree, Promotion and Improvement of Results: Award of Degree: The degree of Master of Pharmacy in any subject shall be awarded on the basis of GPA obtained by a candidate in M.Pharm. In order to qualify for the M.Pharm degree a candidate must have to obtain within 3 (three) academic years from the date of first admission: (i) a minimum GPA of 2.50, (ii) a minimum GP of 2.00 in the Practical/Thesis, and (iii) a minimum TCP of 36. The result shall be given in GPA with the corresponding LG (Table of LG, GP and CP) in bracket. For instance, in the example cited above the result is “GPA = 2.67 (B-)”. Publication of Results: The result of a successful candidate shall be declared on the basis of GPA. The transcript in English shall show the course number, course title, credit, grade and grade point of individual courses, GPA and the corresponding LG. Result Improvement: A candidate obtaining a GPA of less than 2.75 at the examination shall be allowed to improve his/her result, only once as an irregular candidate within 3 academic years from the date of first admission. The year of examination, in the case of a result improvement, shall remain same as that of the regular examination. His/her previous grades for Practical courses, Class assessment/Tutorial/Terminal/Home assignment, Thesis /Dissertation /Project/In-plant training courses shall remain valid (except the Theory Viva voce)***.
Load more

Recommended publications
  • Doctor of Pharmacy (Pharm. D.) SCOPE & PLACEMENTS
    Doctor of Pharmacy (Pharm. D.) (6 Years Post Graduation with Prefix Doctor before your name) Importance, Scope and Placements in India & Abroad About Course Pharm.D. course is introduced by Govt. of India and Pharmacy Council of India, New Delhi in 2008 It was introduced with a vision for improvement of clinical pharmacy services in our country. It is the only pharmacy service which is in direct contact with patient health care system. The Pharm.D. program is a pre-Ph.D., post-graduate professional doctorate. After obtaining Pharm.D. degree, the candidate can put Dr. (Doctor) before his/her name. Duration: 06 years, divided in two phases: Phase-I (05 Years Study) and Phase-II (01 Year Internship/ Residency) Examination pattern: Annual Eligibility: Pass in 10+2 Science (Medical/ Non-Medical) or D.Pharmacy, eligible to get admission in first year of this course. In countries like USA, Australia, Canada etc., this course has central and pivotal role in the health care system. The course aims to prepare eligible candidates students in the management of patient medication therapy and improving patient outcomes. SCOPE & PLACEMENTS Pharm.D. candidates may work in the following fields: Scientist for Clinical Trials: A new drug undergoes various clinical trials on humans under the expertise of pharmacologists. Pharmacovigilance Scientist/Officer: Various companies like Quantum, Herron etc. recruit pharmacologists for the vigilance of various drugs used in the public domain for their new adverse drug effects or new indications etc. Clinical Research Organizations like Parexel, Herron etc. Research fellow in various research projects of government and private agencies.
    [Show full text]
  • Professionals and Academics Degrees in Pharmacy: “Understanding the Designation of Each
    International Journal of Pharmacy Teaching & Practices 2012, Vol.3, Issue 3, 281-282. Professionals and academics Degrees in Pharmacy: “Understanding the designation of each degree and knowing which degree to pursue for the right perspective future work.” Guy Armel Bounda School of Pharmacy,China Pharmaceutical University college or university that is usually awarded in Letter to Editor recognition of the recipient having either satisfactory completed a prescribed course of study.[9] The most Please cite this paper as: Guy Armel Bounda. Professionals and common academic degrees awarded today are academics Degrees in Pharmacy: “Understanding the designation of Bachelor’s, Master’s and Doctoral degrees. The each degree and knowing which degree to pursue for the right modern pharmacy profession has shifted perspective future work.” IJPTP, 2012,3(3),281-282 . considerably away from a product focus and towards Corresponding Author: a patient focus. To cope with these changes, and to meet the demand of the modern pharmacy Guy Armel Bounda profession, the pharmacy curriculum, especially in Clinical Pharmacy, the developed world, has evolved significantly. [6] School of Pharmacy China Pharmaceutical University In the western countries and in several 24# Tong Jia Xiang, Nanjing 210009 countries where their education system is based on P.R.China The United Kingdom or on The United States Email: [email protected] Educational system, BPharm (Bachelor of Letter Comment Pharmacy), MPharm (Master of Pharmacy) and PharmD (Doctor of Pharmacy) are the
    [Show full text]
  • Development and Current Status of Clinical Pharmacy Education in China
    American Journal of Pharmaceutical Education 2014; 78 (8) Article 157. REVIEW Development and Current Status of Clinical Pharmacy Education in China Ming Hu, PhD,a Gary Yee, PharmD,b Naitong Zhou, MS,a Nan Yang, PhD,a Xuehua Jiang, PhD,a and Donald Klepser, PhDb a West School of Pharmacy, Sichuan University, Chengdu, Sichuan Province, China b College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska Submitted October 24, 2013; accepted February 19, 2014; published October 15, 2014. Objective. To describe the current status and developing trend of clinical pharmacy education in China. Methods. Descriptive analysis of data and information about the clinical pharmacy specialty, pharmacy colleges, and curriculum from literature, college websites, and statistics from the Ministry of Health (MOH) and Ministry of Education (MOE) websites was conducted. Results. Clinical pharmacy programs were established in China in 1989 but developed more fully after 2006. In 2012, there were 30 pharmacy colleges with clinical pharmacy undergraduate programs, which included a bachelor’s degree in clinical pharmacy and a clinical pharmacy concentration within the BS programs of pharmacy or medicine. More than 40 colleges within the university system offer 4 types of master’s degree programs in clinical pharmacy. Five universities offer a PhD program in clinical phar- macy. Three postgraduate programs exist, which train hospital pharmacists and clinical pharmacists: the 312 year Hospital Pharmacist Standardized Training Program at Peking hospitals; the 1-year Clinical Pharmacist Training Program sponsored by the MOH; and the 2-year Clinical Pharmacist Residency Program provided by West China Hospital at Sichuan University. Conclusion. A growing clinical pharmacy education system has been established and has become an important subfield in Chinese pharmacy education.
    [Show full text]
  • Pharmacy Education in Australia with a Special Focus on Clinical Pharmacy Education
    JAASP http://www.aaspjournal.org Journal of Asian Association of Schools of Pharmacy 2019; 8: 1–6 © 2019 The Asian Association of Schools of Pharmacy Review Pharmacy education in Australia with a special focus on clinical pharmacy education Shu Chuen Li* Discipline of Pharmacy & Experimental Pharmacology, School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan, Australia Received February 7, 2019 ABSTRACT Revised March 15, 2019 Accepted March 25, 2019 In Australia, there are currently two types of pharmacy programs, a four-year Bachelor of Pharmacy program and a two-year graduate entry Master of Pharmacy Program, offered by * Corresponding author 18 Pharmacy schools. Completion of either degree together with other requirements is the Discipline of Pharmacy & Experimental current basis for registration to practice as a pharmacist. Pharmacology, School of Biomedical The quality of pharmacy education and training in Australia is regulated and monitored by Sciences & Pharmacy, University of Newcastle, Callaghan, NSW 2308, Australia several governmental and professional organizations to ensure its standard. E-mail: [email protected] Postgraduate pharmacy training is also available from several universities in Australia to equip practicing pharmacists with advanced knowledge and skill in clinical pharmacy. Overall, pharmacy education and training in Australia is of high quality and producing practicing pharmacists to fulfil the current need of the local healthcare system. However, the heightened expectation for pharmacist to contribute further in health care delivery will put pressure on pharmacy schools to be more proactive in updating their curricula to meet this need. Key words: pharmacy, education, clinical pharmacy, post graduate training, Australia pharmacy. Students could enter the course at any date and 1.
    [Show full text]
  • G20 Academic Regulation (Appendix) 2017/18
    G20 ACADEMIC REGULATION (APPENDIX) 2017/18 G20 The College has the authority to confer and revoke awards under the Charter and Statutes of King’s College London. All awards have regard to the provisions of the QAA UK Quality Code for Higher Education. Conferment and Revocation G20.1 Academic Board has the authority to award and revoke any degree, diploma, certificate or other award granted by the College in accordance with the Charter and Statutes of King’s College London. Conferment G20.2 The Assessment Boards, acting on the recommendations of their constituent Assessment Sub Boards, the Research Degrees Examination Board and the College Assessment and Standards Committee are the sole bodies having delegated authority to recommend the conferment of the awards for which they are responsible. G20.3 The only occasion when a decision relating to results ratified by the Assessment Board can be modified, is under the provisions of the academic appeals process. Revocations G20.4 Award type, award title or classification can be revoked and reissued, or an award can be revoked in its entirety. G20.5 A revocation may be applied: a) when there is satisfactory proof that there was an administrative error in the award made; b) when, subsequent to award, an Assessment Board takes into account information which was unavailable at the time its original decision was made; or c) following a recommendation by the Misconduct Committee or by an Inquiry Panel established to investigate allegations of research misconduct. Awards G20.6 The awards have regard to the provisions of the QAA’s UK Quality code for higher education and meet the following requirements specified for King’s College London degrees, diplomas and certificates: Undergraduate Certificates (level 4) G20.7 An Undergraduate Certificate is the equivalent of one year’s study of an undergraduate degree at level 4.
    [Show full text]
  • Self Evaluation Report and Description Tartu School of Pharmacy 2008
    University of Tartu Faculty of Medicine Department of Pharmacy SELF-EVALUATION REPORT for the accreditation of curricula : 80419 (8896212) Pharmacy (Bachelor and Master`s integrated studies) 2707 (8505202) Pharmacy (Doctoral studies) 80361 (8896212) Pharmacy (Doctoral studies) Approved by: Head of the Working Group Prof. Peep Veski …………………………….. Signature Date Dean of the Faculty of Medicine Prof. Toomas Asser ……………………………… Signature Date Vice Rector for Prof. Birute Klaas ……………………………… Academic Affairs Signature Date Tartu 2008 1 TABLE OF CONTENT DESCRIPTION OF THE PROCESS OF COMPILING THE SELF-EVALUATION REPORT 1 1. INTRODUCTION 1.1. THE MISSION OF THE UNIVERSITY OF TARTU 2 1.2. BRIEF HISTORY OF THE UNIVERSITY OF TARTU 2 1.3. THE ESTONIAN SYSTEM OF HIGHER EDUCATION 2 1.4 THE STRUCTURE OF THE UNIVERSITY OF TARTU 3 1.5. PRINCIPLES AND ORGANISATION OF QUALITY ASSURANCE AT THE UNIVERSITY 4 1.6. ORGANIZATION AND MANAGEMENT OF THE FACULTY OF MEDICINE 5 1.7. ORGANIZATION AND MANAGEMENT OF THE DEPARTMENT OF PHARMACY 7 2. PHARMACY EDUCATION IN ESTONIA 8 3. THE OBJECTIVES OF THE DEPARTMENT OF PHARMACY 8 4. DESCRIPTION OF THE CURRICULA 9 4.1. HISTORY OF TEACHING OF PHARMACY AT THE UNIVERSITY OF TARTU 9 4.2. CHARACTERISATION OF CURRICULUM: PHARMACY MASTER CURRICULUM 9 4.3. OPENING, MANAGING AND CHANGING OF THE CURRICULUM 11 4.4. CHARACTERISATION OF CURRICULUM: DOCTORAL STUDIES 12 4.5. THE CURRICULUM: STRONG SIDES 12 4.6. THE CURRICULUM: WEAK SIDES 13 4.7. ACTION PLAN 13 4.8. TRAINING PROCESS 13 4.9. TRAINING METHODS 14 4.10. TRAINING PROCESS: STRONG SIDES 16 4.11.
    [Show full text]
  • Department of Pharmacy & Pharmacology
    Department of Pharmacy & Pharmacology Pre-entry Guide 2019-20 for Master of Pharmacy (MPharm) and Master of Pharmacy (MPharm) with integrated pre-registration year Name: …………………………………………. Dear Student, Congratulations on passing your exams and achieving the necessary qualifications to enter the Department of Pharmacy & Pharmacology at the University of Bath! You can be confident that you are embarking on a degree programme which is widely respected in the UK and further afield, and which will give you a strongly positive start to your chosen career in pharmacy. It is my responsibility as Director of Teaching, and MPharm Director of Studies, to ensure that our Department and its academic staff provide you with every opportunity to achieve your potential. We do this primarily by designing integrated MPharm programmes, in which core pharmaceutical sciences, pharmacology and biomedical sciences are taught in a way that emphasises their importance to clinical pharmacy practice. Our MPharm programmes undergo regular review and updates, both to keep their content in line with recent scientific and clinical research, and to take advantage of technological developments so that at least some of that accumulated information can be made available in an easily digestible form to you. A brief outline of the first year of your MPharm programme is provided in this booklet, together with some instructions on what we would like you to do before arriving in Bath to commence your studies. However, the most important point that I wish to emphasise is that, at University, your success (or otherwise!) is much more in your hands than it is in ours.
    [Show full text]
  • Curriculum Vitae 4 Pages
    Curriculum Vitae (short version, 4 pages) 1. FULL NAME Vincenzo Cerullo (ResearchID: B-9075-2015; ORCID: 0000-0003-4901-3796) 2. OTHER INFORMATION Citizenship: Italian Office address: Biocenter 2, Viikinkaari 5E, 00790 Helsinki, Finland Home Address: Uimarinpolku 10C 15, 00330 Helsinki, Finland Marital Status: Married, two children (Victor, 6 and Nicole, 2) 3. EDUCATION AND DEGREE AWARDED 23/10/1998 Master of Pharmacy and Pharmaceutical Chemistry (5 years), score 110/110 cum laude University of Naples “Federico II”. Title of the Thesis: Crellastatin A: A Cytotoxic Bis-Steroid Sulfate from the Vanuatu Marine Sponge Crella sp. Supervisors: Professors Luigi Minale and Mariavaleria D’Auria 3 Jun 1999 Board of Pharmacy 17 Jun 2004 Doctor in Biotechnology, University of L’Aquila and University of Naples “Federico II”. Title of the thesis: Development of Helper-dependent Adenoviral Vectors for gene therapy of Atherosclerosis. Supervisors: Professor Lucio Pastore and Professor Fabrizio Pane. 13 May 2011 Docent (equivalent to adjunct professor or senior lecturer) of Experimental Virology, University of Helsinki. 4. OTHER EDUCATION AND TRAINING, QUALIFICATIONS AND SKILLS - Pedagogy education at University of Helsinki (35ECTs) teaching in higher Education - Clinical trials development and clinical research – ASGCT 5. LINGUISTIC SKILLS Italian: mother tongue English: fluent Spanish: good Finnish: entry (second level Helsingin Aikuisopisto, training still on-going) Swedish: good (wife and son Swedish-speaking) 6. CURRENT POSITION 16/09/2012 Tenure-track
    [Show full text]
  • The Inclusion of a Business Management Module Within the Master of Pharmacy Degree: a Route to Asset Enrichment? Pharmacy Practice 2013 Apr- Jun;11(2):109-117
    Davies MJ, Fleming H, Jones R, Menzie K, Smallwood C, Surendar S. The inclusion of a business management module within the master of pharmacy degree: a route to asset enrichment? Pharmacy Practice 2013 Apr- Jun;11(2):109-117. Original Research The inclusion of a business management module within the master of pharmacy degree: a route to asset enrichment? Michael J. DAVIES, Hannah FLEMING, Richard JONES, Kate MENZIE, Christine SMALLWOOD, Sebastian SURENDAR. Received (first version): 31-Jan-2013 Accepted: 22-May-2013 ABSTRACT* include business owners / lecturers and teaching Background: Over the past decade the profession practitioners covering topics including management, of pharmacy has steadily evolved. The New leadership, interpersonal skills and regulation. We Pharmacy Contract exposed pharmacists to a suggest the inclusion of a business module with the fundamental change in traditional pharmacy MPharm degree would be of great value in business models. preparing individuals for practice within a modern Objective: This study will consider whether day healthcare setting. community pharmacists, pharmacy undergraduates and academic staff within the United Kingdom Keywords: Education, Pharmacy; Students, believe it would be beneficial to incorporate a Pharmacy; Professional Competence; Pharmacy business management module within the Master of Administration; United Kingdom Pharmacy (MPharm) undergraduate degree along with potential mechanisms of delivery. INCLUSIÓN DE UN MÓDULO DE GESTIÓN Methods: Further to ethical approval, the DE EMPRESA EN EL GRADO DE MASTER questionnaire was distributed to UK registered EN FARMACIA: UN CAMINO HACIA LA pharmacists (n=600), MPharm undergraduates MEJORA? (n=441) and academic staff at Liverpool John Moores University (n=44). The questions were formatted as multiple choice questions, Likert scales RESUMEN or the open answer type.
    [Show full text]
  • Conference Proceedings
    European PhD Programmes in Biomedicine and Health Sciences Editors: Zdravko Lacković and Jadranka Božikov Proceedings of the Second European Conference on Harmonisation of PhD Programmes in Biomedicine and Health Sciences - Final version - Zagreb, Croatia, April 22–24, 2005 http://bio.mef.hr/conference Organised by UNIVERSITY OF ZAGREB - MEDICAL SCHOOL With the support of: Association of Medical Schools in Europe (AMSE) Association of Schools of Public Health in the European Region (ASPHER) European Medical Association (EMA) Association for Medical Education in Europe (AMEE) Sponsored by: National Foundation for Science, Higher Ministry of Science, Education and Education and Technological Development Sports of the Republic of Croatia of the Republic of Croatia Zagreb, June 21, 2005 PREFACE This monograph represents proceedings of the Second European Conference on Harmonisation of PhD Programmes in Medicine and Health Sciences held in Zagreb, April 22-24, 2005. The monograph was published prior to the Conference and the underlying final version includes “Guidelines for Organisation of PhD Programmes in Biomedicine and Health Sciences” convened during the Conference as well as the letter, both sent to the Ministerial Conference in Bergen immediately after the Conference. We would like to thank all the contributors including those who sent us their contributions although they were not able to attend the Conference in Zagreb. Editors: Professor Zdravko Lacković, MD, PhD Assoc. Professor Jadranka Božikov, PhD Zagreb, June 17, 2005 C O N T
    [Show full text]
  • Rule Book on Graduate Studies at the University of Zagreb Faculty of Pharmacy and Biochemistry
    RULE BOOK ON GRADUATE STUDIES AT THE UNIVERSITY OF ZAGREB FACULTY OF PHARMACY AND BIOCHEMISTRY June, 2014 1 CONTENTS I GENERAL PROVISIONS 3 II STUDY PROGRAMME 3 III STUDENTS 7 IV ENROLMENT IN THE STUDY 10 V TRANSFER TO OTHER UNIVERSITY STUDIES 12 VI MOBILITY OF STUDENTS 13 VII ORGANIZATION OF TEACHING 14 VIII STUDENT WORKLOAD 15 IX ADVANCEMENT THROUGH THE STUDIES 16 X EXAMINATION 17 XI COMMENDATION AND AWARDING THE STUDENTS 21 XII DIPLOMA THESIS AND FINAL EXAM 23 XIII MONITORING AND IMPROVING THE STUDY QUALITY 24 XIV PARTICIPATION OF STUDENTS IN THE WORK OF THE FACULTY 25 XV TRANSITIONAL AND FINAL PROVISIONS 26 XVI ANNEX I ANNEX II ANNEX III ANNEX IV 2 On the basis of the Science and Higher Education Act (Official Gazette, Nos.123/03, 105/04, 174/04 and 46/07), of the Statute of the University of Zagreb, the Rule Book on Studying at Undergraduate and Graduate Studies at the University of Zagreb, and under Article 98, section 5 of the Statute of the Faculty of Pharmacy and Biochemistry (hereinafter: the Faculty), the University of Zagreb Faculty of Pharmacy and Biochemistry, brings the clarified text of the Rule Book on Studying at Graduate studies at the Faculty of Pharmacy and Biochemistry. The clarified text of the Rule Book on Studying at Graduate Studies at the Faculty of Pharmacy and Biochemistry contains the Rule Book on Studying at Graduate Studies at the University of Zagreb Faculty of Pharmacy and Biochemistry, of 22nd December 2011, Entry No.: 251-62-01-11-24 as well as changes and amendments to the Rule Book on Studying at Graduate Studies at the Faculty of Pharmacy and Biochemistry, of 21st May 2014, which contains the time of its entry into force.
    [Show full text]
  • Spring 2014 80Th Doctoral Ceremony University of Florida President
    C ommencement Commencement SPRING 2014 80th Doctoral Ceremony University of Florida President Dr. J. Bernard Machen Bernie Machen has served as the president of the University of Florida since January of 2004. During that time, he has strengthened the university’s three core missions of teaching, research and service – while developing a fourth mission of economic development. Thanks to his leadership, the university has improved its standing in the national higher education rankings and increased its positive influence on Florida’s economy and quality of life. Today, despite the loss of about a third of its state allocation to annual budget cuts, UF is more comprehensive and dynamic than at he is credited with expanding its health sciences any time in its 160-year history. program, stabilizing the university’s finances and bolstering diversity. Milestones of Dr. Machen’s tenure include: • Growth in annual research funding from From 1995 to 1997, Dr. Machen was provost and $470 million in 2003-04 to $644 million in executive vice president for academic affairs at the the current fiscal year. University of Michigan, and from 1989 until 1995, • More than 2.8 million square feet in new he served as dean of Michigan’s School of Dentistry. construction on campus, including nearly From 1983 to 1989, he was professor and associate 600,000 square feet of new research space. dean at the University of North Carolina Chapel • Completion of UF’s $1.7 billion capital Hill’s School of Dentistry. campaign. • The 40-acre public private partnership known Dr. Machen has held several prominent positions in as Innovation Square and the Innovation Hub national higher education leadership.
    [Show full text]